World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 21 November 2016
Main ID:  NCT02965066
Date of registration: 11/11/2016
Prospective Registration: No
Primary sponsor: Coloplast A/S
Public title: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheter in Healthy Volunteers
Scientific title: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheter in Healthy Volunteers
Date of first enrolment: September 2016
Target sample size: 28
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02965066
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science  
Phase:  N/A
Countries of recruitment
Denmark
Contacts
Name:     Per Bagi, MD
Address: 
Telephone:
Email:
Affiliation:  MD at the clinic of urology at Rigshospitalet
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Have given written informed consent and signed letter of authority

2. Be at least 18 years of age and have full legal capacity

3. Be a male

4. Willing to refrain from using analgetics up to 24 hours prior to catheterization
visits

5. Have a negative urine multistix - erythrocytes (Microscopic haematuria)

6. Have a negative urine multistix:

- Leukocytes

- Nitrite Or if positive, subsequent negative for bacterial growth in urine
culture

Exclusion Criteria:

1. Abnormalities, diseases or surgical procedures performed in the lower urinary tract

2. Symptoms of urinary tract infections (at least one of the following: frequent
urination, stinging or pain at urination)

3. Participating in other clinical investigations related to urinary tracts system
during this investigation (inclusion to termination) or have previously participated
in this investigation

4. Known hypersensitivity toward any of the test products -



Age minimum: 18 Years
Age maximum: N/A
Gender: Male
Health Condition(s) or Problem(s) studied
Incontinence, Urinary
Intervention(s)
Device: Coloplast Speedicath
Device: Coloplast Test Catheter
Primary Outcome(s)
Pain [Time Frame: 1 day]
Secondary Outcome(s)
Secondary ID(s)
CP269
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history